Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Revelation Biosciences, Inc. (REVB) had Free Cash Flow of $-6.30M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.68M |
|
-- |
|
-- |
|
$1.94M |
|
$-1.94M |
|
$0.04M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.94M |
|
$-1.94M |
|
2.65M |
|
2.65M |
|
$-1.77 |
|
$-1.77 |
|
| Balance Sheet Financials | |
$12.83M |
|
$0.02M |
|
$0.02M |
|
$12.86M |
|
$1.85M |
|
-- |
|
-- |
|
$1.85M |
|
$11.00M |
|
$11.00M |
|
$11.00M |
|
3.59M |
|
| Cash Flow Statement Financials | |
$-6.30M |
|
-- |
|
$12.51M |
|
$6.50M |
|
$12.71M |
|
$6.21M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-6.30M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.34% |
|
-17.34% |
|
-14.83% |
|
-17.34% |
|
$3.07 |
|
$-2.38 |
|
$-2.38 |
|